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The generation of reactive oxygen species (ROS) is a normal occurrence in the life 
of a cell. ROS are derived from both exogenous and endogenous sources and take 
part in a plethora of normal physiological mechanisms from host immunity to cell 
cycle regulation. However, ROS also exhibit a deleterious, disruptive character that 
means they must now be taken seriously as a genuine carcinogenic agent able to 
alter a variety of pathways leading to the initiation of cancer. The two-sidedness of 
ROS means that the relationship between ROS and the onset and progression of 
cancer is hard to determine. ROS and reactive nitrogen species (RNS) are able to 
initiate cancer through the damage of DNA leading to the genetic instability that 
drives the early stages of cancer. Simultaneously, they can activate a number of 
signalling cascades and transcription factors that facilitate uncontrolled cell growth. 
The production of ROS in neoplastic cells can lead to the production of new blood 
vessels that provide the machinery for subsequent metastasis and tumour invasion. 
It is important that the role of ROS in these pathways are fully elucidated in order to 
provide potential therapies measures.    
 
Introduction 
The toxicity of oxygen in biological systems is an unfortunate paradox given that 
much of life is dependent on the molecule for survival. It is only recently that the 
profound implications of the oxygen paradox have come to the fore, as has the role 
that oxidative stress plays in cellular damage and disruption. Oxidative stress was 
first demonstrated to damage living organisms in 1952 when Conger and Fairchild 
demonstrated the presence of chromosomal aberrations in pollen grains due to 
increased oxygen pressure [1]. Since then, many destructive functions of oxygen 
and its derivatives have been elucidated with human cancer, amongst other 
diseases such as atherosclerosis, at the centre of investigation. It is now widely 
accepted that oxidative DNA damage is a predominant factor in the aetiology of 
human cancer and reactive oxygen species (ROS) have been found to induce many 
forms of DNA damage that can often lead to genetic instability and the initiation of 
cancerous growth [2]. ROS and reactive nitrogen species (RNS) have been shown to 
participate in a plethora of factors that lead to neoplastic transformation, including 
deregulation of intracellular signalling pathways and cell cycle control. This review 
will outline the major pathways affected by free radicals and how this dysregulation 




can ultimately lead to malignant cancerous growth. Attention will first be drawn to the 
key oxidative players in neoplastic transformation and how the action of ROS and 
RNS can promote neoplastic transformation.  
Reactive Oxygen Species  
Free radicals are chemical species that possess one or more unpaired electrons and 
are able to react with each other to produce new radical species, which can result in 
a chain reaction of radical formation [3]. However, ROS refers to both the radical and 
non-radical derivatives of oxygen. As molecular oxygen is abundant in normal 
cellular conditions, free radical propagation involving reactive oxygen species is a 
common place event within the cell. Common free oxygen radicals include hydroxyl 
radical (•OH), nitric oxide (•NO), superoxide (O2
•-) and singlet oxygen [2]. 
ROS in Neoplastic Transformation   
Under normal redox conditions ROS have been implicated in initiation of apoptosis, 
cell cycle arrest and cellular senescence. In apoptopic processes, ROS generation is 
attributed to the uncoupling of the electron transport chain and to a decrease in 
mitochondrial membrane potential. Furthermore, oxidation of mitochondrial 
membrane proteins by ROS may contribute to cytochrome c release due to further 
disruption of mitochondrial membrane potential However, under oxidative stress 
ROS can act in stark contrast by stimulating carcinogenesis [4]. Cancer development 
is a multistage process requiring the cumulative action of multiple deleterious events 
that occur in one cell clone. These events include a three stage model which include 
a permanent change in the genetic material of one somatic cell (initiation); the 
expansion of the mutated cell clone (promotion); and the malignant conversion into 
cancer (progression) (see Valko et al., 2006 [6]). ROS play a prominent role in all 
three stages of cell transformation and act to interfere in a number of crucial 
pathways including DNA repair, signal transduction, angiogenesis, apoptopic 
inhibition and metastasis [5].  
Tumour Initiation 
ROS induced DNA damage 
For initiation of carcinogenesis, a permanent genetic alteration must occur in a given 
cell that will ultimately be inherited by the progeny of the cell. However, the DNA 
modification must be sufficiently tenacious as to escape efficient repair mechanisms, 
but not so excessive that apoptosis ensues [7]. A persistent overproduction of ROS 
can lead to consecutive DNA lesions that can lead to cell transformation, as shown 
by the presence of oxidative modifications of DNA in malignant cancer cells [8]. In 
particular, production of hydroxyl radical in proximity to DNA generates a whole 
series of DNA damage by a variety of mechanisms. Chemical alteration of 
deoxyribose elements by the hydroxyl radical leads to the release of purine and 
pyrimidine bases, producing abasic sites that have shown to be mutagenic in vivo. 
Furthermore, hydroxyl radical attack of DNA generates radical adducts within 
adenine and guanine residues that results in ring-fragmented bases such as the 5-
formamido-4,6-diamino-pyrmidine and 8-hydroxy-guanine (8-OH-Gua) [9]. Due to its 
lowest oxidation potential guanine is the most easily oxidised among the four DNA 
bases. Hydroxyl radical can attack C-4, C-5, and C-8 of a guanine nucleobase 
generating the radicals G4OH•, G5OH• and G8OH• respectively. The radical adducts 
G4OH• and G5OH• can eliminate a molecule of water giving G(-H)• radical which, by 
gaining an electron and protonation, is transformed back to guanine. However, the 




adduct G8OH• subsequently produces two forms of DNA damage: reduction of the 
adduct’s form in which the radical is localised on N-7 gives hemi-aminal which opens 
the imidazole ring forming 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FAPyG). 
Alternatively, oxidation of the C-4 and C-2 resonance forms of G8OH• followed by 
the loss of a proton yields 8-OH-Gua [10].    
8-OH-Gua is the most ubiquitous oxidative DNA base lesion occurring in 
approximately one in 105 guanine residues in a normal cell and therefore, the most 
widely studied lesion. 8-OH-Gua is able to induce GC → TA transversions and 
mutagenesis unless repaired prior to DNA replication [5]. GC → TA transversions are 
frequently detected in the RAS oncogene and represent a possible mechanism of 
tumour initiation by ROS [13]. Moreover, recent studies have suggested a positive 
correlation between tumour size and 8-OH-Gua concentration, offering itself as a 
potential biomarker in the early stages of tumour initiation and promotion [14].  
Several other ROS modified bases have also been shown to possess miscoding 
potential and pre-mutagenic properties including 2-hydroxyadenine, 8-
hydroxyadenine, 5-hydroxyctosine and 5-hydroxyuracil. Whereas the hydroxyl 
radical is almost indiscriminate in its attack upon DNA, singlet oxygen is much more 
selective. It is inefficient at producing strand breakage and generates mainly 
guanine-derived products including 8-OH-Gua and FAPyG, although also common in 
hydroxyl-mediated DNA damage [13]. DNA polymerase is known to be sensitive to 
damage induced errors at guanine residues and the contribution of oxidative damage 
to polymerase-specific ‘hotspots’ is a major contributor to DNA polymerase-mediated 
mutagenesis [14]. It should be noted that DNA damage caused by oxidative stress 
need not necessarily involve direct attack on DNA by ROS and RNS [15]. ROS are 
able to influence intracellular free calcium (Ca2+) levels by depleting endogenous 
antioxidant stores, providing an important signal leading to Ca2+ mobilisation. The 
result of ROS-mediated Ca2+ changes is the activation of endonucleases leading to 
DNA fragmentation [5]. For the most part, many of the ROS induced oxidative 
damage will be successfully repaired by DNA repair mechanisms. It has been 
estimated that 2 x 104 DNA damaging events occur per cell per day and a large 
proportion of this figure is ROS induced [3] and therefore, ROS species play a major 
part in introducing genetic instability within the cell, especially under oxidative stress. 
This genetic instability is merely the first step in neoplastic transformation that can 
ultimately lead to tumour promotion in the progeny.  
Tumour Promotion 
In addition to the ROS-mediated mutagenesis involved in initiation and cancer 
progression, oxidative stress can stimulate the expansion of mutated cell clones by 
modulating genes related to cell proliferation and cell death. While high levels of 
oxidative stress inhibits proliferation via cytotoxic effects, intermediate levels can 
stimulate cell division and therefore, promote tumour growth (fig 1.). This 
characteristic relationship between free radical levels and tumour promotion may 
provide an explanation as to why higher tolerance to oxidative stress, due to 
increased antioxidant levels, can lead to a promotable phenotype [15]. ROS have 
been observed to influence a number of intracellular signalling pathways that leads 
to subsequent activation of transcription factors associated with cell proliferation and 
inhibition of cell death.  
 




Oxidative Stress, Cell signalling and Transcription Factors  
As mentioned above, the effect of ROS in defining cell fate is concentration 
dependent. At low concentrations, superoxide and hydrogen peroxide in fact 
stimulate cell proliferation and enhanced cell survival by acting as secondary 
messengers in a number of signalling cascades. This section will review the major 
signalling pathways influenced by ROS and how their subsequent stimulation can 
lead to the activation of transcription factors involved in cell proliferation [6]. 
Non-receptor Tyrosine Kinases 
Several non-receptor protein kinases (PTKs) belonging to the Src family and Janus 
kinase (JAK) are also activated by ROS. Hydrogen peroxide and superoxide radicals 
are able to induce tyrosine phosphorylation of several PTKs in various cell types 
including fibroblasts, T and B lymphocytes, macrophages and myeloid cells. Over 
expression of Src has been associated with colorectal, breast, pancreas, bladder 
and head/neck cancers. Activated Src binds to cell membranes by myristilation and 
initiates mitogen-activated protein kinases (MAPKs), NF-κB and phosphoinositide 3-
kinase (PI3K) signalling pathways resulting in cell proliferation [16]. 
Protein Tyrosine Phosphatases 
Protein tyrosine phosphatases (PTPs) are arguably the best characterised direct 
targets of ROS. Reversible inhibition of PTPs by ROS plays an essential role in 
redox control and cell signalling and furthermore, inactivation of PTPs can directly 
trigger protein tyrosine kinase activation. The effects of ROS occur through targeting 
the cysteine-containing residues of the active sites of tyrosine phosphatases as 
cysteine residues are highly susceptible to oxidative damage, particularly through 
hydrogen peroxide. The reaction generates sulphenic acid intermediates that further 
react with thiols to form catalytically inactive PTP disulfides. Thus, not only are ROS 
involved in the excessive stimulation of activatory pathways, they initiate a double 
blow to the cell by knocking out inhibitory mechanisms mediated by protein tyrosine 
phosphatases [16][17]. 
Serine/threonine Kinases  
The ability of free radicals to induce large increases in cytosolic Ca2+ levels has a 
knock on effect for many serine/threonine kinases and ultimately the transcription 
factors they in turn activate. The induction of proto-oncogene c-FOS by low levels of 
ROS was found to be directly mediated by cytosolic Ca2+ [18]. The activation of 
protein kinase C (PKC) by ROS also mediated in part by Ca2+, leading to the 
phosphorylation and activation S6-kinase which is involved in the acquisition of 
growth competence [19]. PKC contains several cysteine-rich regions both in the zinc 
finger of the regulatory domain and in the catalytic site, which can be modified by 
various ROS. Both regulatory and catalytic domains of PKC are susceptible to 
hydrogen peroxide-induced modification, often leading to its activation. PKC is 
thought to mediate many of the ROS induced cell proliferation events [6]. A number 
of serine and threonine kinases of the mitogen-activated protein kinase (MAPK) 
family can also be regulated as well as activated by ROS. The role of MAPKs in 
carcinogenesis is a complicated story in view that activation of many MAPK 
pathways is tissue and stimuli specific. There are four known MAPK families: 
extracellular-regulated (ERKs), c-jun-NH2-terminal kinase (JNK), p38 MAPK and the 
big MAPK-1 (BMAPK-1).  Products of NAD(P)H oxidase 1 (NOX1) activity, 
superoxide and hydrogen peroxide, have been shown to activate MAPK cascades at 
the level of MEK and ERK1/2 [16]. However, it has also been reported that 




endogenous hydrogen peroxide production by the respiratory burst induces ERK but 
not p38 kinase activity [20]. On the other hand, exogenous hydrogen peroxide 
preferentially activates p38 but not ERK in rat alveolar macrophages [16].  
Furthermore, p38α is able to initiate apoptosis in response to oncogene-induced 
ROS accumulation and plays a key role in the regulation of malignant transformation 
although, interestingly, highly tumourigenic human cancer cells can override this 
aspect of p38α function and therefore, promote cell survival [21]. This example 
highlights the complex nature of the relationship between ROS and signal 
transduction pathways. It must be noted that the association is not only cell specific 
but concentration dependent. Often, under normal physiological conditions, ROS act 
to inhibit NF-κB rather than activate it, thereby initiating apoptosis and inhibiting cell 
proliferation. It is the oxidation of cysteine residues in the DNA binding domain of the 
p50 subunit by ROS that affects the DNA-binding capacity of NF-κB. This complex 
involvement of ROS is carried forward upon activation of transcription factors. 
NF-κB    
NF-κB is a redox regulated transcription factor and a sensor for oxidative stress and 
plays a major role in cell proliferation [22]. Composed primarily of a heterodimer 
consisting of the subunits p50 (NF-κB1) and p65 (relA). Transcription factors of the 
NF-κB/c-Rel family can be directly activated by application of oxidising agents, 
especially hydrogen peroxide, although hypoxia is also able to induce nuclear 
translocation of NF-κB and NF-κB activation [23]. Storz et al. [24] demonstrated an 
important role for the serine/threonine kinase PKD in the activation of NF-κB via the 
IκB kinase (IKK) complex in cells exposed to hydrogen peroxide [24]. The IKK 
complex is thought to play a prominent role in the ROS-mediated activation of NF-
κB. Oxidation of cysteine179 of IKKα and IKKβ binds IKK with other components of 
the signalosome maintaining them in a more stable conformation. Furthermore, it 
has been postulated that certain components of the signalosome are maintained in a 
non-functional form by a redox sensitive inhibitor such as thioredoxin, which has 
been shown to inhibit members of the MAP3K family. Therefore, ROS-dependent 
activation of MAP3K family members is a result of potential inhibitors like thioredoxin, 
leading to subsequent NF-κB activation [25][26]. NF-κB activation pathways 
associated with cancer are uncoupled from their normal modes of regulation and in 
cancer cells a constitutive NF-κB activation has been illustrated. For example, BCR-
Abl transformed cells show constitutive activation of NF-κB and Hodgkin disease has 
been associated with a mutation in the gene which encodes IκBα [26]. NF-κB has 
been implicated in the development of leukemia and lymphoma as well as a host of 
carcinomas including breast, gastric and colorectal. ROS-induced NF-kB activation 
can also stimulate many of the genetic alterations required to render cells 
tumourigenic including the activation of growth stimulatory targets such as 
interleukin-2 (IL-2), granulocyte macrophage-colony stimulating factor (GM-CSF), 
CD40L; regulation of the cell cycle through G1 cyclins and c-Myc and inhibit 
apoptosis [15]. Consequently, NF-κB plays a prominent role in the progression of 
neoplastic cells. Although its pleiotropic effects are often complex and yet to be fully 
understood, further investigation can provide possibilities for potential development 
of therapeutic strategies.  
AP-1 and HIF-1 
AP-1 is an assembly of dimeric basic region-leucine zipper (bZIP) proteins that 
belong to the Jun, Fos, Maf, and ATF subfamilies. AP-1 activity is initiated on 
activation of MAPK signalling pathways and like NF-κB, plays a key role in cell 




proliferation. Activation of the transcription factor by hydrogen peroxide is mediated 
by JNK and p38 MAPK cascades and subsequent ROS-mediated inhibition of MAPK 
phosphatases also leads to increased MAPK activation and therefore, increased AP-
1 expression. ROS are also known to promote the expression of c-Fos and c-Jun 
which act as positive regulators of cell proliferation as well as function as positive or 
negative regulators of apoptosis [6] Hydrogen peroxide, in addition to nitric oxide, 
has also been shown to up regulate the expression of hypoxia-inducible factor 1 
(HIF-1), a heterodimer consisting of HIF-1α and HIF-1β (arylhydrocarbon receptor-
nuclear translocator [ARNT]) [22]. While ARNT is constitutively expressed, it is the 
HIF-1α subunit that carries the sensitivity towards molecular oxygen.  HIF-1 
regulates the expression of a variety of genes expressed in neoplastic cells such as 
vascular endothelial growth factor (VEGF), which plays a key role in angiogenesis, 
aldolase, enolase and lactate dehydrogenase. HIF-1, as well as being expressed 
under hypoxic conditions, is induced by the expression of oncogenes Src and Ras 
and therefore HIF-1 is over expressed in many cancers [28]. 
p53 
The inactivation and loss of tumour suppressor genes marks a critical point in the 
progression of neoplastic transformation. At this junction the mechanisms that inhibit 
cell growth after DNA damage has incurred cease to function and cell proliferation is 
left to take place unregulated and indefinitely [7]. p53 is a prominent tumour 
suppressor gene with over 70% of cancers bearing defects in p53 function. p53 
controls cell cycle via a multitude of molecular pathways and is able to induce 
apoptosis through transcriptional regulation of pro-apoptopic proteins. A study by 
Souici et al [29] found that p53 exposure to nitric oxide leads to GC → TA transitions 
in the first base of codon 248 of the p53 gene. This mutation results in an amino acid 
change abolishing the wild-type function of the protein supporting the notion that 
nitric oxide is a potent carcinogenic agent, particularly under inflammatory 
conditions. A positive correlation has been observed between GC → TA transitions at 
CpG dinucleotide sites in the p53 gene and inducible nitric oxide synthase activity 
[30]. The likelihood of nitric oxide induced mutation of p53 appears to increase at 
sites of chronic inflammation where there is a continual production of nitric oxide by 
nitric oxide synthase. High mutation rates in a number of p53 gene codons have 
been observed in inflamed lesions of the colon with patients with ulcerative colitis 
[31]. Elevated GC → AT transitional mutations have also been observed in lymphoid, 
oesophageal, head, stomach, brain and breast cancers which also demonstrate 
increased iNOS levels [32] However, under many normal physiological conditions, 
ROS promote increased expression of p53 leading to greater cell cycle arrest and in 
many instances, cell senescence [33]. So, as seems to be the recurring theme with 
ROS induced neoplastic transformation, the picture is far from clear. Increased ROS 
levels actually lead to an accumulation of p53 in the cell so once again an important 
concentration dependent mechanism is in place. It is firmly established the nitric 
oxide can induce p53 mutation but more work needs to be done to investigate the 
cell specific, ROS specific, and concentration relationship between various other 
important ROS in p53 dysfunction.  
Tumour Progression 
The final stage of cancer development is the acquisition of malignant properties by 
the tumour including accelerated growth; escape of immune surveillance; 
angiogenesis; and metastasis. Most of these changes require further formation of 
DNA lesions and through elevated ROS levels, tumour cells remain in a consistent 




state of oxidative stress that can increase genomic instability and metastatic 
potential [15]. Conversely, many tumours exhibit regions of hypoxia which results in 
the activation of signalling pathways leading to increased cell proliferation and 
angiogenesis. However, the presence of hypoxia in malignant tumours is its self a 
response to inadequate rates of angiogenesis [34], hinting at the presence of a 
feedback mechanism at work in malignant cells. The adaptation of cancerous cells to 
survive under hypoxia is a key feature of transformed cells that contributes 
significantly to their survival and aggressive phenotypes. The reoxygenation of blood 
and the reperfusion of hypoxic tissue can increase the concentration of ROS. ROS 
produced via this reoxygeneration have many damaging effects but can also 
stimulate angiogenesis which constitutes one of the most significant events in 
tumour progression [35]. Blood flow within newly generated vessels is often chaotic 
which leads to further bouts of hypoxia, followed by subsequent reperfusion events 
causing the release of additional ROS [4]. ROS can induce the production of 
angiogenic factors VEGF and interleukin-8 (IL-8) and can promote the secretion of 
matrix metalloprotease-1 (MMP-1) which also promotes vessel growth within the 
tumour microenvironment. Furthermore, oxidative stress can trigger vasodilation on 
activation of heme oxygenase-1, which generates carbon monoxide and iNOS which 
generates nitric oxide. Both can act as vasodilators. Generation of new blood 
vessels increases the risk of blood born metastasis that can considerably increase a 
tumour’s invasiveness [4]. When certain neoplastic cells are under oxidative stress 
they exhibit decreased attachment to the basal lamina and thus, are more able to 
detach themselves from basement membranes and enter the vasculature [36]. ROS 
regulate cell adhesion by modulating integrin function and integrin-induced signalling 
pathways in which Rac1 is thought to play a prominent role by altering cell to cell and 
cell to matrix adhesion, influencing cancer cell motility and invasion. Rac1 activity is 
in turn able to induce ROS production in endothelial cells and functions in ROS-
mediated actin cytoskeleton rearrangement [4].  
Conclusion 
The generation of ROS is a consequence of aerobic life and is unavoidable. ROS 
represent a constant source of assault upon DNA, which promotes genetic instability 
that can lead to the initiation of cancerous growth [6]. It is now firmly established that 
oxidative stress plays a key role in all stages of cancer that begins with the altering 
of DNA and ends with malignancy and tumour invasion. ROS can influence many of 
the signal transduction pathways that mediate cell proliferation and apoptosis that 
can eventually lead to uncontrolled neoplastic growth. In tumour promotion, the 
production of ROS can modulate neovascularisation, an important step in the 
potential onset of metastasis. However, the relationship between ROS and the onset 
of cancer is far from being clearly defined. In many cases increased levels of ROS 
can protect against cancer by inducing apoptosis, the immune response to 
transformed cells is often to increase levels of oxidative stress to initiate cytotoxic 
mechanisms in the host cell. Therefore, it appears that intermediate to low levels of 
ROS results in tumour initiation [37]. Particularly in the case of carcinomas, hypoxia 
actually drives cancer progression through the onset of angiogenesis. This 
complicated picture has especially drastic consequences for cancer therapy. If high 
levels of ROS can protect against cell proliferation, then therapeutics in the form of 
antioxidants that target ROS to be scavenged can increase tumour initiation.  It is for 
that reason that new research must now also focus on the role of antioxidants in 
chemoprevention in order to characterise accurately their potential therapeutic roles 




in a range of tissues and cancers. Antioxidants gained from dietary intake are a key 
focal point as much is made of their potential to fight against illnesses including 
cancer and atherosclerosis. However, investigations so far have produced much 
conflicting evidence. Dietary components such as green tea are often consumed in 
the hope that they can provide vital antioxidants that can protect against oxidative-
induced transformation. It is imperative then, that we fully understand the antioxidant 
composition of such foods so that we can apply that knowledge to potential therapies 
in targeting reactive oxygen species in neoplastic transformation.   
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